![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Soliton Earns Additional FDA Clearance for Rapid Acoustic Pulse Device
Soliton Earns Additional FDA Clearance for Rapid Acoustic Pulse Device
![ClearanceStamp_Blue.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Blue.gif?t=1576043968&width=430)
Soliton has received additional FDA 510(k) clearance for Resonic, a rapid acoustic pulse (RAP) device, clearing modifications that improve its use.
The device includes a new autoloading cartridge for the RAP system and an improved user interface. The product delivers rapid pulses of acoustic shockwaves to assist lasers in skin-related treatments.
The RAP device first received clearance for tattoo removal in May 2019. This was followed by 510(k) clearance for treating cellulite in February 2021.
Upcoming Events
-
21Oct